Use this Clindamycin pediatric dose calculator to match the prescribed child dose to the exact liquid, tablet, or capsule strength before you give it.
dose calculator basics
Use this Clindamycin calculator as the fast parent page for weight-based dose checks, mL conversion, common strengths, and the practical safety steps that generic calculator sites often skip.
mL per dose = (child weight in kg x prescribed mg/kg/day / doses per day) / medication concentration in mg per mL.
For a 20 kg child using 30 mg/kg/day divided 3 times daily with 75 mg/5 mL, calculate the daily mg target, divide by the schedule, then convert that mg amount into mL for the selected product.
Practical dosing guide
Use this page to match the prescribed Clindamycin plan to the exact product strength and schedule before the first dose.
Clindamycin is a lincosamide antibiotic used in children for skin and soft-tissue infections, including MRSA coverage in some regions, and as an alternative for penicillin-allergic patients. Typical pediatric dosing is 20–40 mg/kg/day divided every 6–8 hours.
Weight‑based dosing: 20–40 mg/kg/day divided q6–8h
Common oral suspension concentration: 75 mg/5 mL (palmitate)
Clindamycin is a targeted option for selected toxin-mediated, MRSA-suspected, and anaerobic infections when susceptibility and patient risk profile support its use.
Purulent skin and soft-tissue infections: First-line only when local MRSA susceptibility supports clindamycin use.
Necrotizing fasciitis and streptococcal toxic shock (adjunct): Adjunctive therapy for toxin suppression; always combine with beta-lactam and surgical management.
Aspiration pneumonia with anaerobic predominance: Use only when beta-lactams are not tolerated and anaerobic coverage is needed.
Osteomyelitis or septic arthritis (culture-confirmed clindamycin susceptibility): Use only with confirmed susceptibility and negative D-test.
Pelvic inflammatory disease in adolescents with severe beta-lactam allergy: Reserve for severe beta-lactam allergy and ensure close follow-up.
Legacy infective endocarditis prophylaxis pathways (historical reference): Recent AHA guidance no longer prefers clindamycin for routine dental endocarditis prophylaxis because of adverse-event concerns; use current guideline alternatives.
Clindamycin is effective for selected infections but has a higher gastrointestinal adverse-effect burden than many alternatives. Families need clear guidance on what can be monitored at home versus when to stop and seek urgent evaluation.
Clindamycin is a lincosamide antibiotic that binds the 23S rRNA of the 50S ribosomal subunit and blocks peptide chain elongation. This stops bacterial protein synthesis and can be bacteriostatic or bactericidal depending on the organism and inoculum. Clindamycin penetrates bone and abscesses well and suppresses streptococcal and staphylococcal toxin production, which makes it useful in toxin-mediated infections. Resistance can occur through ribosomal methylation (erm genes), so a D-test is important when Staphylococcus aureus is erythromycin resistant. Gastrointestinal adverse effects, including C. difficile colitis, are key risks that require counseling and monitoring.
Most regimens are every 6–8 hours. Set alarms or use school nurse support for midday doses so levels stay steady.
Yes. A light snack such as toast or applesauce eases nausea without affecting how well it works. Avoid large dairy servings right at dosing time.
For mild loose stools, continue the medication, offer fluids, and add probiotics. Stop and call immediately if diarrhea is watery, bloody, or paired with stomach cramps or fever.
Yes, clindamycin is not a penicillin. Still, watch for new rashes or swelling and let us know about any past severe reactions.
Try chilling the suspension, following with a small flavored drink, or using a reward chart. Call us if doses are missed so we can discuss alternatives.
Fever and swelling often improve within 48–72 hours. Keep giving the full course even if they feel better, and reach out if symptoms worsen or linger beyond 3 days.
idsa-ssti-2014
cid-ssti-2014
statpearls-nec-fasciitis-2024
aafp-aspiration-2019
idsa-cap-2011
aap-osteomyelitis-2020